Optimizing Protection for NSTE-ACS Patients with Antiplatelet Therapy
A Series of Live Visiting Professor Programs
and an OnDemand CME Webcourse
Welcome to "Optimizing Protection for NSTE-ACS Patients with Antiplatelet Therapy."
Despite advances in acute and chronic treatment of acute coronary syndrome (ACS) patients, there is still considerable uncertainty among physicians about the relative benefits of various antiplatelet agents in protecting against long-term ischemic complications. This CME-certified program explores the limitations of current antiplatelet therapies and how they might be best managed. In addition, participants are alerted to the potential importance of emerging therapies that can transform the clinical management of these patients. "Optimizing Protection for NSTE-ACS Patients with Antiplatelet Therapy" is being presented live at hospitals across the nation. You can also view this important new online program now and receive CME credit. Click on the link below to access the full, online program.
In conjunction with this program, a handy Clinical Atlas practice tool and treatment guide has been developed to aid health care professionals who manage ACS patients following PCI.
This reference guide examines:
- Post-PCI clinical practice standards
- Recommended dosing of antiplatelet agents
- Response variability of current antiplatelet agents
- Effects of dual antiplatelet therapy and increased dosages on clinical outcomes
- Newer oral antiplatelet agents in development
To access this interactive Clinical Atlas, click on animated icon above.